The stock price soared to $31.22 by the end of the first day of trading.
Nearly 11 percent growth is forecast for presbyopia-correcting lenses globally in 2015 and 2016.
He calls the former headquarters the largest and most important site in the new Allergan’s system.
Ford was appointed executive vice president of medical devices in June.
Ron Kurtz, MD, and Eric Weinberg add wealth of ophthalmic experience.
Procedure volume is expected to increase at a compounded annual rate of 3.4 percent over the next five years.
An estimated 15.5 million ultrasonic phaco procedures will be performed worldwide in 2015.
White House takes issue with some proposals, including marketing of off-label uses of products.
Consolidation activity accelerated after the Supreme Court’s ruling in favor of health care subsidies.
The stock market’s reaction to the news may have oversimplified the study’s results.
The agency says advancements in technology have significantly reduced operating time and improved safety and patient outcomes.
DE-122 is an anti-endoglin antibody first developed for cancer treatment.
The ApertureRx appears to be pointed toward the same lower cost market as the Zepto capsulotomy system.
Sinskey was an early adopter of phacoemulsification in 1972 and played an important role in development and acceptance of the procedure.
You are not currently logged in.
©2017 Market Scope
Lost your Password